Frequency of Early Occlusion and Stenosis in a Left Internal Mammary Artery to Left Anterior Descending Artery Bypass Graft After Surgery Through a Median Sternotomy on Conventional Bypass
- 7 December 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (23) , 2353-2358
- https://doi.org/10.1161/01.cir.100.23.2353
Abstract
Background—Uncertainty exists regarding the frequency of early occlusion when the left internal mammary artery (LIMA) is anastomosed to the left anterior descending artery (LAD) through a sternotomy with conventional coronary artery bypass grafting (CABG). The issue has gained importance for comparison with less invasive surgical approaches in which operative exposure may be limited and graft anastomosis more difficult. Methods and Results—Data were analyzed from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial in which 617 patients underwent conventional CABG of the LAD with a LIMA between April 1993 and May 1995. Coronary angiography was performed a mean of 10.8 days postoperatively. Patients were randomized to receive intraoperative aprotinin, an inhibitor of several serine proteinases, or placebo. Because no differences existed in patency rates of LIMA grafts between patients who received aprotinin and placebo, both groups were analyzed collectively. On coronary angiography, the LIMA was widely patent (<50% stenosis) in 561 patients (91%), had ≥50% and 98% when anastomosed to the LAD. These data provide an important benchmark for less invasive surgical approaches in which the LIMA is anastomosed to the LAD.Keywords
This publication has 29 references indexed in Scilit:
- Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trialThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Minimally invasive coronary artery bypass grafting versus coronary angioplasty for isolated type C stenosis of the left anterior descending arteryThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose RegimensThe Annals of Thoracic Surgery, 1996
- Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 yearJournal of the American College of Cardiology, 1994
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery.Circulation, 1983
- Angiographic Changes in Internal Mammary Artery and Saphenous Vein Grafts, Two Weeks, One Year and Five Years after Coronary Bypass SurgeryScandinavian Journal of Thoracic and Cardiovascular Surgery, 1981